Login to Your Account

Challenges are global

Trial recruitment easier in China? Not so fast, according to analysis

By Elise Mak
Staff Writer

Wednesday, March 7, 2018

HONG KONG – The sheer speed of growth of the biotech and med-tech industries in China has easily outpaced the development of regulation and has led to concerns that too many of the ballooning number of clinical trials in the country fail to meet enrollment targets.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription